Skip to content

Effects of gender differences on anesthesia sensitivity in thyroid cancer patients:An analysis based on electroencephalogram mechanism

Effects of gender differences on anesthesia sensitivity in thyroid cancer patients:An analysis based on electroencephalogram mechanism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124628
Enrollment
Unknown
Registered
2026-05-14
Start date
2026-05-18
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

Young women thyroid cancer anesthesia sensitivity observation group:None
Young male thyroid cancer anesthesia sensitivity observation group:None
Middle-aged women thyroid cancer anesthesia sensitivity observation group:None
Middle-aged male thyroid cancer anesthesia sensitivity observation group:None

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age: 18-65 years old; 2.ASA grade I-II; 3.BMI 18-30kg/m^2; 4.The menstrual cycle regularity of young female patients ( menstrual cycle regularity is defined as continuous 23-35 days, and the cycle length fluctuation does not exceed 2 days ); 5.Patients undergoing thyroid surgery; 6.Voluntary signing of informed consent.

Exclusion criteria

Exclusion criteria: 1.The following conditions are exclusion criteria: previous history of neurological diseases (epilepsy, stroke, severe traumatic brain injury); history of severe mental illness (such as schizophrenia); long-term use of psychoactive drugs or sedatives; history of drug abuse; severe liver and kidney dysfunction (Child-Pugh C, eGFR < 30 ml/min); sex hormone or related drug treatment within 6 weeks; thyroid dysfunction; history of hypothalamic or pituitary disease; allergy to sevoflurane; inability to cooperate with EEG monitoring; pregnancy or lactation; and hearing impairment.

Design outcomes

Primary

MeasureTime frame
The end - tidal concentration of sevoflurane;

Secondary

MeasureTime frame
Prefrontal lobe EEG data;Vital signs data;Awakening period score;Quality of recovery;

Countries

China

Contacts

Public ContactXuemei Sun

The First Affiliated Hospital of Anhui Medical University

18715519369@126.com+86 551 6292 2384

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026